Search - tctmd.com

Displaying 1 - 20 of 34

Sort: Relevancy | Date

News Daily News

NOBLE at 5 Years: New Data Favor CABG for Left Main Disease

Todd Neale

December 23, 2019

News Daily News

Aspirin Not Protective Against CVD in Black Patients

Caitlin E. Cox

December 18, 2019

News Daily News

EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up

Michael O'Riordan

December 10, 2019

News Daily News

For Real-world ACS Patients, FFR Use in PCI Tied to Lower In-Hospital Mortality

Michael O'Riordan

December 05, 2019

News Conference News AHA 2019

More Adverse Events, Higher Costs With Impella: New Observational Studies

Caitlin E. Cox

November 17, 2019

News Daily News

Women Face Greater Post-PCI Stroke Risk Than Men, Study Confirms

Caitlin E. Cox

November 15, 2019

News Conference News TCT 2019

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

Caitlin E. Cox

October 10, 2019

News Conference News TCT 2019

EXCEL at 5 Years: PCI for Left Main CAD Still Noninferior to CABG

Marcus A. Banks

September 28, 2019

https://www.tctmd.com/news/ideal-lm-probes-short-dapt-and-bioabsorbable-polymer-stent-left-main-disease

News Conference News TCT 2019

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Michael O'Riordan

September 26, 2019

News

Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia

Michael O'Riordan

September 24, 2019

News Daily News

Higher Mortality With Off-Pump CABG: EXCEL Analysis

Michael O'Riordan

August 08, 2019

News Daily News

Stroke After PCI: Rare but Rising as Patient Complexity Climbs

Todd Neale

August 05, 2019

News Daily News

Same-Day Discharge Safe After Elective PCI, Canadian Study Affirms

Marcus A. Banks

June 25, 2019

News Daily News

Platelet Function and Genetic Testing to Guide P2Y12 Inhibitor Meds in PCI: Updated Consensus

Caitlin E. Cox

June 13, 2019

News Conference News EAS 2019

Absence of FH Diagnosis Linked to Increased Risk of Premature Mortality

Michael O'Riordan

June 05, 2019

News Conference News SCAI 2019

FFR Changes Treatment Plan in More Than One-Third of All-Comer Patients

Yael L. Maxwell

June 04, 2019

News Conference News SCAI 2019

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

Yael L. Maxwell

May 30, 2019

News Conference News EAS 2019

CHD Mortality Significantly Elevated in Patients With Severe FH

Michael O'Riordan

May 29, 2019

News Conference News SCAI 2019

National Cardiogenic Shock Initiative Shows Potential to Increase Survival

Yael L. Maxwell

May 23, 2019

News Daily News

Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure?

Yael L. Maxwell

May 15, 2019

Advertisement

NOBLE at 5 Years: New Data Favor CABG for Left Main Disease

Aspirin Not Protective Against CVD in Black Patients

EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up

For Real-world ACS Patients, FFR Use in PCI Tied to Lower In-Hospital Mortality

More Adverse Events, Higher Costs With Impella: New Observational Studies

Women Face Greater Post-PCI Stroke Risk Than Men, Study Confirms

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

EXCEL at 5 Years: PCI for Left Main CAD Still Noninferior to CABG

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia

Higher Mortality With Off-Pump CABG: EXCEL Analysis

Stroke After PCI: Rare but Rising as Patient Complexity Climbs

Same-Day Discharge Safe After Elective PCI, Canadian Study Affirms

Platelet Function and Genetic Testing to Guide P2Y12 Inhibitor Meds in PCI: Updated Consensus

Absence of FH Diagnosis Linked to Increased Risk of Premature Mortality

FFR Changes Treatment Plan in More Than One-Third of All-Comer Patients

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

CHD Mortality Significantly Elevated in Patients With Severe FH

National Cardiogenic Shock Initiative Shows Potential to Increase Survival

Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content